Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Urinary Tract" wg kryterium: Temat


Wyświetlanie 1-2 z 2
Tytuł:
Antibiotic Susceptibility Profiling of Bacterial Biodiversity Associated with Urinary Tract Infections
Autorzy:
Prasad, Bhairav
Arora, Priya
Powiązania:
https://bibliotekanauki.pl/articles/1193375.pdf
Data publikacji:
2021
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
Antibiotics
Escherichia coli
Klebsiella
Pseudomonas
Sensitivity profiling
Staphylococcus
Urinary system
Urinary tract infections
Opis:
Urinary tract infections (UTI’s) are a bacterial infection that affects any part of the urinary tract. Urinary tract infection is one of the major diseases that affect people of all age groups and sexes and can be separated into asymptomatic and symptomatic. The normal urinary tract is sterile but gets infected with the normal flora and opportunistic pathogens. Urinary tract infections (UTIs) are a serious health problem affecting millions of people each year. This is the second most common type of infection in the body. In the present study 20 morphologically different bacterial isolates were recovered from 50 different urine samples from UTI’s patient. The prevalence of the isolates was varied with E. coli (40%), followed by Staphylococcus spp., Pseudomonas spp. and Klebsiella spp. each of (20%) respectively. All the isolates of different bacteria were tested for antibiotic sensitivity patterns against common antibiotics viz. Ampicillin, Tetracycline, Chloramphenicol, Vancomycin, Nitrofurontione and Ciprofloxacin with potencies of 30 μg each. The sensitive pattern of the isolates towards antibiotic Nitrofurontoine was (75%) followed by Tetracycline (55%) and Ciprofloxacin (45%). Intermediate activity was reported against Ampicillin (45%), Chloramphenicol and vancomycin (40%). Resistant pattern shown against vancomycin (60%), Chloramphenicol (45%), while both tetracycline and Ciprofloxacin shown (30%) against the UTI’s isolates. Therefore, drugs like Nitrofurontoine, Tetracycline and Ciprofloxacin are the most effective choices against the common UTI’s isolates.
Źródło:
World Scientific News; 2021, 155; 129-139
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Innovative Thermobalancing therapy can help millions of men with enlarged prostate gland to improve the quality of life and well-being throughout the world
Autorzy:
Allen, Simon
Powiązania:
https://bibliotekanauki.pl/articles/1166902.pdf
Data publikacji:
2018
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
aging men
bph treatment
enlarged prostate
longevity
lower urinary tract symptoms
thermobalancing therapy
Opis:
Millions of men across the world suffer from enlarged prostate or benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms (LUTS). Medications and surgical procedures for BPH have serious side effects, reducing quality of life and wellbeing. 10 years empirical evidence and outcomes of a clinical study have shown effectiveness of innovative Thermobalancing therapy (TT) with Dr Allen’s therapeutic device (DATD) to treat the cause of BPH. Dynamics of urinary symptoms by International Prostate Symptom Score, quality of life (QoL), ultrasound prostate volume (PV mL) and uroflowmetry (maximum flow rate, Qmax mL/s) were evaluated at the beginning and end of the study in 124 patients who received TT for 6 months, comparing with no-treatment group. TT has diminished PV from 45 mL to 31 mL (P<0.001) and the urinary symptoms from 14.2 to 4.9 (P<0.001), increased Qmax 8.1 to 17.7 mL/s (P<0.001) and improved QoL from 3.9 to 1.3(P<0.001). Thus, the obtained data explores the substantial positive changes in PV and urine flow rate and, consequently, the significant improvement of urinary symptoms and QoL after use of TT with DATD as mono-therapy. Given the lack of side effects after use of DATD, which should be expected after BPH drugs and operations, it should be stated that TT should be used worldwide as first line treatment for men with LUTS due to BPH to improve men’s health and wellbeing.
Źródło:
World Scientific News; 2018, 105; 51-61
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies